Quick Overview
essiac tea cancer | buy essiac
Essiac tea, can be used to help support the Immune System, clean and detoxify the blood and vital organs, help prevent the onset of everything from colds to more serious health concerns.
essiac tea, the four main herbs that make up ESSIAC® are Burdock Root, Sheep Sorrel, Slippery Elm Inner Bark, and Indian Rhubarb Root. essiac tea, the four herbs may help normalize body systems by cleansing the blood, purging toxic build up, promoting cell repair and aiding in effective assimilation and elimination. Sheep Sorrel acts on the endocrinal system. Burdock Root apparently eliminates free radicals and purifies the blood. Slippery Elm is believed to dissolve mucous deposits in tissue, glands and nerve channels, soothing inflamed membranes and organs. Indian Rhubarb reportedly helps the body, especially the liver rid itself of wastes and toxins.
essiac tea can be used to help support the Immune System, clean and detoxify the blood and vital organs, help prevent the onset of everything from colds to more serious health concerns.
essiac tea, herbs are grown without the use of herbicides or pesticides. Used in Canada and exported worldwide. GMP compliance.
Nurse Rene M. Caisse is world renowned for having made significant contributions to the field of natural medicine. From 1922 to 1978, Nurse Caisse used ESSIAC®, her original herbal formula, to help alleviate pain and suffering and restore health to people worldwide.
benefits associated with Essiac during standard breast-cancer treatment. Additionally, we described the pattern of use of Essiac in this cohort of women.
performed a retrospective cohort study in 510 women, randomly chosen from the Ontario Cancer Tumour Registry, with a diagnosis of primary breast cancer in 2003.
With the exception changes in a Physical well-being subscale and a relationship with doctor subscale, Essiac did not have a significant effect on HR-QOL or mood states. Even for Physical well-being and relationship with doctor, Essiac seemed to have a negative effect, with Essiac users doing worse than the non-Essiac users. This might be attributed to the fact that the group of users comprised younger women with more advanced stages of breast cancer, and both of these subgroups of patients have been shown to be at a significantly increased risk for negative mood states and/or a decreased sense of well-being. The women were taking low doses (total daily dose 43.6 +/- 30.8 mL) of Essiac that corresponded to the label directions found on most Essiac products.